Novartis’ Entresto falls short at Phase 3 in heart failure with preserved ejection fraction
July 29, 2019Research and Development, Sales and Marketing Entresto, Novartis, heart failure, pharma
Novartis has been rocked by new Phase 3 data from a global trial into the efficacy of Entresto (sacubitril/valsartan), revealing …
Bernie Sanders says price hiking pharma execs are murderers
July 29, 2019Sales and Marketing
Bernie Sanders has stood by his claim that those artificially raising the price for insulin are murderers. Speaking on Saturday …
Top Ten most popular articles on Pharmafile.com this week
July 26, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biohaven, FDA, Lyrica, NICE, Pfizer, UK, US, pharma, top ten
At the end of a week that could certainly be called “eventful” here in the UK – one that saw …
London’s water contains high levels of antibiotic-resistant genes, UCL research reveals
July 26, 2019Medical Communications, Research and Development London, UCL, UK, antibiotic resistance, pharma
Research from University College London has warned that freshwater sources in the English capital of London contain high levels of …
GW Pharma’s cannabis-based Epidyolex edges closer to EU approval with positive CHMP opinion in epilepsy
July 26, 2019Medical Communications, Sales and Marketing EMA, Epidiolex, Europe, GW Pharma, cannabis, epilepsy
UK-based biotech GW Pharmaceuticals has announced that its cannabidiol oral solution Epidyolex has secured recommendation from the European Medicines Agency’s …
J&J’s ponesimod meets primary and secondary endpoints at Phase 3 in relapsing multiple sclerosis
July 26, 2019Medical Communications, Research and Development Johnson & Johnson, multiple sclerosis, pharma, ponesimod
New Phase 3 data has been released on Johnson & Johnson’s selective sphingosine-1-phosphate receptor 1 (S1P1) modulator ponesimod, reporting that …
AstraZeneca’s Lynparza approved via Cancer Drugs Fund for BRCA+ gynaecological cancers
July 26, 2019Medical Communications, Sales and Marketing AstraZeneca, Cancer, Cancer Drugs Fund, NHS, NICE, UK, lynparza, pharma
NICE has published final guidance which approves AstraZeneca’s Lynparza (olaparib) for use on the NHS as a maintenance therapy for …
Vertex promote chief medical officer to CEO as Jeffrey Leiden steps down
July 25, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Dr Reshma Kewalramani has been made the new Vertex CEO. Vertex’s Chief Medical Officer Dr Kewalramani will succeed current CEO …
Christi Shaw taken on by Gilead as Kite Pharma’s new CEO
July 25, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Lilly veteran Christi Shaw has joined Kite Pharma as the company’s new CEO. Shaw comes to Gilead’s cancer immunotherapy firm, …
BMS’ blockbuster Opdivo flies high and falls short in non-small cell lung cancer
July 25, 2019Research and Development Bristol-Myers Squibb, NSCLC, immuntherapy, lung cancer, opdivo, pharma
Bristol-Myers Squibb has pulled back the veil on new data from two analyses of its blockbuster immunotherapy Opdivo (nivolumab) in …
MRI scans can help predict MS patient’s long term prognosis, 15 year study shows
July 25, 2019Research and Development CIS, MRI scans, MS, Prognosis, diagnosis, multiple sclerosis, pharma
MRI scans can predict MS patient’s long term prognosis when they are first diagnosed, according to new research. In a …
Researchers design automatic opioid overdose antidote device
July 25, 2019Research and Development naloxone, opioid crisis, opioids, pharma, purdue university
Researchers at Purdue University are developing a device that would automatically detect an overdose in opioid users and release a …
Lilly’s Baqsimi nasal powder gains FDA approval after proving non-inferior to injection
July 25, 2019Sales and Marketing Baqsimi, Eli Lilly, FDA, US, diabetes, pharma
Eli Lilly has been awarded approval from the FDA for its Baqsimi nasal powder in the treatment of severe hypoglycaemia, …
Elizabeth Warren calls on Albert Bourla to reveal detail of appointment of former FDA commissioner Scott Gottlieb to Pfizer’s board
July 25, 2019Business Services, Medical Communications Albert Bourla, Elizabeth Warren, FDA, Pfizer, Scott Gottlieb, pharma
Elizabeth Warren has called on Pfizer to reveal the details of Scott Gottlieb’s appointment to the company’s Board of Directors.
GSK hire Jonathan Symonds as new Chairman
July 24, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Business chief Jonathan Symonds has joined British multinational GlaxoSmithKline as the company’s new non-executive chairman. The hire ends GSK’s six …
ABPI Chief Executive Mike Thompson to retire by the end of 2019
July 24, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Chief Executive Mike Thompson is to retire from his role at the Association of the British Pharmaceutical Industry (ABPI) by …
Humira biosimilar from Samsung Bioepis and MSD wins marketing authorisation in the US
July 24, 2019Research and Development, Sales and Marketing AbbVie, Humira, MSD, Samsung Bioepis, biosimilars, pharma
It’s another victory for MSD as the US drugmaker announced that its biosimilar version of AbbVie’s Humira – the world’s …
Senate puts forward bipartisan bill to lower price of drugs
July 24, 2019Research and Development PBMs, Senate, USA, access, bipartisan, pharma, pricing
The Senate Finance Committee has introduced a bipartisan bill that aimed at lowering the prices Medicare pays for pharmaceutical drugs. …
FDA approves Pfizer’s biosimilar version of Genentech’s Rituxan
July 24, 2019Research and Development FDA, Pfizer, Rituxan, Ruxience, biosimilars, pharma
Pfizer has seen Ruxience, its biosimilar version of Genentech’s Rituxan (rituximab), approved by the FDA in the treatment of non-Hodgkin …
Researchers use machine learning to re-identify ‘anonymous data’
July 24, 2019Research and Development Big Data, anonymous data, data, patient data, privacy, research
Anonymised data can be traced back to individuals, according to research published in the journal Nature Communications. Anonymised data can …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
